Abiopharma

New Form 144 - Stoke Therapeutics, Inc. Filed: 2025-08-29 AccNo: 0001950047-25-006555 Size: 7 KB

New Form 144 - SERA PROGNOSTICS, INC. Filed: 2025-08-29 AccNo: 0001950047-25-006553 Size: 6 KB

New Form S-1 - bioAffinity Technologies, Inc. Filed: 2025-08-29 AccNo: 0001641172-25-025990 Size: 855 KB

New Form 8-K - GT Biopharma, Inc. Filed: 2025-08-29 AccNo: 0001493152-25-012479 Size: 230 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

New Form 144 - COHERENT CORP. Filed: 2025-08-29 AccNo: 0001950047-25-006545 Size: 4 KB

New Form 8-K - TriSalus Life Sciences, Inc. Filed: 2025-08-29 AccNo: 0001826667-25-000129 Size: 187 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Mock James M 🟡 adjusted position in 535 shares (2 derivative) of Moderna, Inc. (MRNA) at $25.10 Transaction Date: Aug 27, 2025 | Filing ID: 021032

New Form 424B5 - Canopy Growth Corp Filed: 2025-08-29 AccNo: 0001104659-25-085662 Size: 666 KB

Director Indig Chaim 🟡 adjusted position in 100.0K shares (4 derivative) of Phreesia, Inc. (PHR) at $32.47 ($4.7M) Transaction Date: Aug 27, 2025 | Filing ID: 021030

New Form 8-K - Sana Biotechnology, Inc. Filed: 2025-08-29 AccNo: 0001193125-25-192766 Size: 164 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

New Form S-3 - PDS Biotechnology Corp Filed: 2025-08-29 AccNo: 0001140361-25-033423 Size: 1 MB

New Form 8-K - Century Therapeutics, Inc. Filed: 2025-08-29 AccNo: 0001104659-25-085658 Size: 195 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Roberts Evan 🔴 sold 48.5K shares of Phreesia, Inc. (PHR) at $32.46 ($1.6M) Transaction Date: Aug 27, 2025 | Filing ID: 021029

New Form SCHEDULE 13G/A - PMGC Holdings Inc. Filed: 2025-08-29 AccNo: 0001079973-25-001402 Size: 8 KB

Klinger Shannon Thyme 🟡 adjusted position in 535 shares (2 derivative) of Moderna, Inc. (MRNA) at $25.10 Transaction Date: Aug 27, 2025 | Filing ID: 021028